Independent register of U.S. FDA drug recalls · updated Oct 10, 2026
RxRecalls Get alerts

FDA Drug Recalls

111 recalls, newest first

Class I · High risk

Lotrimin AF

Chemical Contamination: presence of benzene

Terminated Chemical / undeclared Bayer Healthcare Pharmaceuticals Inc. NDC 11523-0010-2 D-0249-2022
Class I · High risk

Lotrimin Af

Chemical Contamination: presence of benzene

Terminated Chemical / undeclared Bayer Healthcare Pharmaceuticals Inc. NDC 11523-0544-2 D-0248-2022
Class I · High risk

Lotrimin Af

Chemical Contamination: presence of benzene

Terminated Chemical / undeclared Bayer Healthcare Pharmaceuticals Inc. NDC 11523-4140-2 D-0247-2022
Class I · High risk

Lotrimin Af

Chemical Contamination: presence of benzene

Terminated Chemical / undeclared Bayer Healthcare Pharmaceuticals Inc. NDC 11523-1272-2 D-0246-2022
Class II · Moderate risk

Tinactin (Tolnaftate 1%)

cGMP Deviations: manufactured at the same facility where other lots were found to be contaminated with benzene.

Terminated Chemical / undeclared Bayer Healthcare Pharmaceuticals Inc. NDC 11523-0777-2 D-0245-2022
Class II · Moderate risk

Tinactin (Tolnaftate 1%)

cGMP Deviations: manufactured at the same facility where other lots were found to be contaminated with benzene.

Terminated Chemical / undeclared Bayer Healthcare Pharmaceuticals Inc. NDC 11523-0072-5 D-0244-2022
Class II · Moderate risk

Tinactin (Tolnaftate 1%)

cGMP Deviations: manufactured at the same facility where other lots were found to be contaminated with benzene.

Terminated Chemical / undeclared Bayer Healthcare Pharmaceuticals Inc. NDC 11523-0165-3 D-0243-2022
Class II · Moderate risk

Tinactin (Tolnaftate 1%)

cGMP Deviations: manufactured at the same facility where other lots were found to be contaminated with benzene.

Terminated Chemical / undeclared Bayer Healthcare Pharmaceuticals Inc. NDC 11523-4162-1 D-0242-2022
Class II · Moderate risk

Lotrimin AF

cGMP Deviations: manufactured at the same facility where other lots were found to be contaminated with benzene.

Terminated Chemical / undeclared Bayer Healthcare Pharmaceuticals Inc. NDC 11523-4327-1 D-0241-2022
Class II · Moderate risk

Lotrimin Af

cGMP Deviations: manufactured at the same facility where other lots were found to be contaminated with benzene.

Terminated Chemical / undeclared Bayer Healthcare Pharmaceuticals Inc. NDC 11523-0010-2 D-0240-2022
Class II · Moderate risk

Lotrimin Af

cGMP Deviations: manufactured at the same facility where other lots were found to be contaminated with benzene.

Terminated Chemical / undeclared Bayer Healthcare Pharmaceuticals Inc. NDC 11523-0010-1 D-0239-2022
Class II · Moderate risk

Lotrimin Af

cGMP Deviations: manufactured at the same facility where other lots were found to be contaminated with benzene.

Terminated Chemical / undeclared Bayer Healthcare Pharmaceuticals Inc. NDC 11523-0544-2 D-0238-2022
Class II · Moderate risk

Lotrimin Af

cGMP Deviations: manufactured at the same facility where other lots were found to be contaminated with benzene.

Terminated Chemical / undeclared Bayer Healthcare Pharmaceuticals Inc. NDC 11523-4140-2 D-0237-2022
Class II · Moderate risk

Lotrimin Af

cGMP Deviations: manufactured at the same facility where other lots were found to be contaminated with benzene.

Terminated Chemical / undeclared Bayer Healthcare Pharmaceuticals Inc. NDC 11523-1272-2 D-0236-2022
Class I · High risk

365 SKINNY High Intensity Capsules

Marketed Without an Approved NDA/ANDA: FDA analysis found the product to be tainted with undeclared sibutramine, a previously approved drug that was withdrawn from the US market due to safety concerns.

Terminated Chemical / undeclared Je Dois Lavoir LLC D-0631-2022

Recalls by year